This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Accretive Health And Cancer Clinics Of Excellence To Develop Innovative Program Providing Oncology Care Management

Accretive Health, Inc. (NYSE:AH), a healthcare technology and services company, and Cancer Clinics of Excellence (CCE), a national network of practice-owned, physician-driven community-based oncology practices, announced today that they have partnered to develop a novel, end-to-end oncology care management offering designed to enable healthcare providers to improve the efficacy and quality of cancer care while simultaneously improving the affordability of the healthcare system.

“Since our inception, we have been developing solutions that provide our members’ practices with the opportunity to enhance the way they deliver and monitor care,” said Ike Nicoll, CEO of Cancer Clinics of Excellence. “By partnering with Accretive Health, we will jointly provide our network of practices with the infrastructure , and a team of experienced advisers to build a model that creates more coordinated and integrated care that will deliver better outcomes for patients while containing costs.”

Dr. Arthur Staddon, Chairman of CCE’s Board of Directors and an oncologist at Pennsylvania Oncology Hematology Associates, added, “Long a proponent of providing evidence-based care in our practices, we are equally committed to affordable care, and we believe this partnership with Accretive Health moves CCE’s network practices one step closer to making that goal a reality.”

Cancer Clinics of Excellence today is comprised of community-based oncologists in 15 states. The National Cancer Institute estimates that the vast majority of cancer patients (about 85 percent) are treated at community-based oncology practices.

“We are delighted to work with a leading healthcare organization that has been setting new standards in the effective treatment of cancer,” said Mary Tolan, CEO of Accretive Health. “Our investments and technology to help providers organizations succeed in population health management will be a cornerstone of this program, along with our commitment to enhance the care of patients by providing people, process, and technology solutions for provider organizations.”

Tim Barry, President of Quality at Accretive Health, said, “CCE has long recognized that there are clear opportunities to improve cancer care while improving the affordability of healthcare for all stakeholders. They also share a deep belief that this type of improvement in healthcare can only be sustained when we invest in resources designed to help foster the physician-patient relationship. We are delighted to be able to work with this forward-thinking organization to help improve their own model for care delivery and to set an example for others about what can be achieved through new approaches to managing the continuum of care.”

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs